Corey Michael Watton, Director at ZEVRA THERAPEUTICS, INC. (ZVRA), bought 300 shares at $7.84 ($2K) on 2025-03-28, disclosed to the SEC on 2025-03-31.
Open-market purchase of $2k ZVRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ZVRA | BUY | 2023-06-26 | $2K | — | Filing → |
| ZVRA | BUY | 2023-06-13 | $2K | — | Filing → |
| ZVRA | BUY | 2023-05-31 | $2K | — | Filing → |